These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6171216)

  • 1. LHRH and analogues as potential therapy for benign prostatic hyperplasia and hormone-dependent cancers.
    Auclair C; Stern M; Givner ML
    Arch Androl; 1981 Nov; 7(3):237-44. PubMed ID: 6171216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of flutamide action on prostatic and testicular functions in the rat.
    Marchetti B; Labrie F
    J Steroid Biochem; 1988 Jun; 29(6):691-8. PubMed ID: 2838689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medrogestone and an LHRH analogue as potential combination therapy for hormone-dependent cancers.
    Auclair C; Givner ML
    Arch Androl; 1982 Feb; 8(1):21-4. PubMed ID: 7039538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent tissues in the rat.
    Séguin C; Cusan L; Bélanger A; Kelly PA; Labrie F; Raynaud JP
    Mol Cell Endocrinol; 1981 Jan; 21(1):37-41. PubMed ID: 6259002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an LHRH agonist on endocrine function, LHRH receptor and LH/hCG receptor in the pituitary-gonadal axis of male rats.
    Komatsu M; Iwahana H; Mitsuhashi S
    Endocrinol Jpn; 1986 Apr; 33(2):185-95. PubMed ID: 3019649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effects of LHRH on LH receptors in the rat testis].
    Auclair C; Ferland L; Cusan L; Kelly PA; Labrie F; Azadian-Boulanger G; Raynaud JP
    C R Acad Hebd Seances Acad Sci D; 1978 May; 286(18):1305-7. PubMed ID: 208798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of gonadal functions in the adult male rat following cessation of five-month daily treatment with an LHRH agonist.
    Lefebvre FA; Bélanger A; Pelletier G; Labrie F
    J Androl; 1984; 5(3):181-92. PubMed ID: 6086556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the direct action of luteinizing hormone-releasing hormone agonists at the testicular level in intact rats treated with an antiluteinizing hormone serum.
    Séguin C; Bélanger A; Labrie F; Hansel W
    Endocrinology; 1982 Feb; 110(2):524-30. PubMed ID: 6276140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat.
    Auclair C; Kelly PA; Coy DH; Schally AV; Labrie F
    Endocrinology; 1977 Dec; 101(6):1890-3. PubMed ID: 201452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration in the normal pattern of serum testosterone and 5 alpha-androstane-3 alpha, 17 beta-diol in the immature male rat following chronic treatment with luteinizing hormone releasing hormone or luteinizing hormone.
    Wisner JR; Stalvey JR
    Steroids; 1980 Sep; 36(3):337-48. PubMed ID: 7001679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female rats.
    Cusan L; Auclair C; Belanger A; Ferland L; Kelly PA; Seguin C; Labrie F
    Endocrinology; 1979 May; 104(5):1369-76. PubMed ID: 220032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat.
    Lefebvre FA; Séguin C; Bélanger A; Caron S; Sairam MR; Raynaud JP; Labrie F
    Prostate; 1982; 3(6):569-78. PubMed ID: 6296803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.
    Warner B; Worgul TJ; Drago J; Demers L; Dufau M; Max D; Santen RJ
    J Clin Invest; 1983 Jun; 71(6):1842-53. PubMed ID: 6408125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of oestrogen and GnRH agonist analogue-induced inhibition of the pituitary-testicular function in rat.
    Huhtaniemi IT; Warren DD; Catt KJ
    Acta Endocrinol (Copenh); 1983 Jun; 103(2):163-71. PubMed ID: 6305079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
    Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
    Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 2-week combination therapy with the luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide and the antiandrogen flutamide on prostate structure and steroid levels in the dog.
    Lacoste D; Dubé D; Bélanger A; Labrie F
    Mol Cell Endocrinol; 1989 Dec; 67(2-3):131-8. PubMed ID: 2693158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the chronic administration of a potent luteinizing hormone releasing hormone analog on the rat prostate.
    Trachtenberg J
    J Urol; 1982 Nov; 128(5):1097-100. PubMed ID: 6294350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881).
    van Roijen JH; Ooms MP; Weber RF; Brinkmann AO; Grootegoed JA; Vreeburg JT
    J Androl; 1997; 18(1):51-61. PubMed ID: 9089068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proopiomelanocortin-derived peptides in testicular interstitial fluid: characterization and changes in secretion after human chorionic gonadotropin or luteinizing hormone-releasing hormone analog treatment.
    Valenca MM; Negro-Vilar A
    Endocrinology; 1986 Jan; 118(1):32-7. PubMed ID: 3000742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.